Mitral Valve Stenosis Market Business Scenario, Share, Growth, Insights, Industry Analysis, Trends and Forecasts Report 2028

 

Mitral Valve Stenosis Market Overview

The Global Mitral Valve Stenosis Market is anticipated to grow significantly over the forecast period 2018 to 2023. Mitral valve stenosis occurs when then the mitral valve opening in the heart is narrowed. The mitral valve is located on the left side of the heart between the two chambers namely the atrium and the ventricle. In this condition, enough amount of blood does not flow through the mitral valve. Scarring caused by rheumatic fever is considered to be the major cause of mitral valve stenosis.

The growing prevalence of heart diseases, increasing occurrences of rheumatic fever, technological advancements coupled with the introduction of novel mitral valves are anticipated to boost the growth of the market during the assessment period. According to a study by researchers at the Stanford University School of Medicine in 2017, it was found that more than 50,000 people in the United States undergo either aortic- or mitral valve replacement surgery each year. On the other hand, the stringent government regulation for drug and medical device approval and the high cost of mitral valve surgeries may hamper the growth of the market.

Request Free Sample Copy at:

https://www.marketresearchfuture.com/sample_request/6560

Regional Analysis

The market in the Americas is expected to dominate the global mitral valve stenosis market. The market growth in this region is majorly attributed to the presence of well-established healthcare sector, rising prevalence of cardiac diseases, increasing preference for minimally invasive surgeries, and growing healthcare expenditure. Europe is anticipated to hold the second largest position in the global mitral valve stenosis market. The market growth in this region is attributed to the increasing prevalence of heart diseases and rising expenditure for the healthcare sector. According to the UK factsheet August 2018 by the British Heart Foundation, there are about 7 million people living with heart and circulatory diseases in the UK. Asia-Pacific mitral valve stenosis market is anticipated to be the fastest growing market. Rising burden of heart diseases, improvement in clinical trial regulations, increasing preference for advanced medical technologies, the rise in medical tourism, and increasing investments in the healthcare sector are anticipated to drive the market growth in this region. The Middle East & Africa has the least market share in the global mitral valve stenosis market.

Segmentation

The global mitral valve stenosis market has been segmented into diagnostic tests, treatment, and end user.

The global market, on the basis of diagnostic tests, has been segmented into electrocardiogram (ECG), transthoracic echocardiogram, transesophageal echocardiogram, cardiac catheterization, and others.

The global market, on the basis of treatment, has been segmented into medication and procedures. The medication segmented is further classified into diuretics, blood thinners, beta blockers, anti-arrhythmic drugs, and antibiotics. The procedures segment has been further segmented into mitral valvuloplasty and mitral valve surgery. The mitral surgery segment has been further classified into mitral valve repair and mitral valve replacement. The procedures segment is anticipated to hold the largest market share on the basis of treatment due to the growing number of companies engaged in the development of medical devices for mitral valve stenosis.

The global market, by end user, has been segmented into hospital & clinics, diagnostic centers, and others.

Key Players

Some of the key players in the global mitral valve stenosis market are Medtronic Plc, Edward Lifesciences, Boston Scientific Corporation, Abbott Laboratories, HighLife Medical, Neovasc Inc., CryoLife, Inc., On-X Life Technologies, Inc., Braun Melsungen AG, JenaValve Technology, Siemens Healthcare, and Micro Interventional Devices, Inc.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/mitral-valve-stenosis-market-6560

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Asthma Inhaler Device market poised to achieve significant growth in the years to come

  Asthma Inhaler Device Market Overview The global asthma inhaler devices market is likely to expand at 5.2 % CAGR during the forecast period (2017-2022) owing to the increasing prevalence of asthma among the crowd, asserts Market Research Future (MRFR). An inflammatory disease of the lungs, asthma is characterized by the difficulty faced while breathing. The symptoms of asthma are often triggered with exposure to allergens such as ragweed, pollen, animal dander, and irritants such as chemical fumes and smoke. Asthma leads to swelling of the inside walls of an asthmatic’s airways and makes airways sensitive to irritations. Drivers and Constraints Impacting the Market With the increasing prevalence of asthma especially among the children, the market is likely to propel over the assessment period. For instance, around 9 million children under five years of age die every year due to the presence of lung diseases. The increasing disposable income and rising preference for combinati...
Read more

Surgical Drapes and Gowns Market Trends with worldwide Industry Analysis, Features, Top Player and Forecast 2030

Image
  Surgical Drapes and Gowns Market Overview The Global Surgical Drapes and Gowns anticipated to have held a market value of USD 2.23 billion in the year 2017 and is expected to grow at a CAGR of 4.4% during the forecast period. Surgical drapes and surgical gowns are used during surgery to maintain sterile surgical field and reduce the risk of contamination and prevention of surgical site infection. Surgical drapes and surgical gowns are used by patients and healthcare professional such as, nurses and doctors. Hospitals, clinics and ambulatory surgical centers are the major end user of the surgical drapes and surgical gowns products. Similarly, According to Public Health England, during 2016 to 2017 around 139,691 procedures were performed in NHS based hospitals in England and about 1,635 surgical site infections (SSIs) detected during the same period. Increasing number of surgeries in healthcare settings and high incidences of hospital-acquired infections are expec...
Read more

Blood Grouping Reagents Market is Expected to Grow at a CAGR of 7.74% by 2027

  Blood Grouping Reagents Market Overview The global blood grouping reagents market is expected to register a CAGR of   7.74%  during the forecast period and is expected to hit USD 2,642.17 million by 2027. Blood grouping reagents are solutions that can be used to determine ABO, Rhesus, Kell and MNS blood groups These classifications of human blood are all based on the presence or absence of certain antigens on the surface of red blood cells. The growth of the global blood grouping reagents market is expected to be driven by increasing prevalence of chronic disorders, increasing spending in medical research. However, concern pertaining to efficiency and proficiency of test kits hamper the growth of this market. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10725 Segment Analysis The global blood grouping reagents market is mainly segmented into product, technique, and test type, end user. On the basis of product, the blood groupin...
Read more